Study of Comparison Between Pentacam and locs3

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Study Classification

OBSERVATIONAL

Study Start Date

2008-12-31

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypothesis: There is no difference between pentacam scheimpflug system and locs3 in grading of cataract.

Major aims:

1. research the efficiency of pentacam scheimpflug system in lens density measurment.
2. To compare the pentacam with the locs3 in grading of cataract.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

cataract locs3 pentacam

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* cataract patient
* age\>18

Exclusion Criteria

* pregnant women
* any disease of the eye except for cataract
* patients who are ineligible by law to take decisions by themselves.patients who have a custodian.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nadav Belfair, MD . Soroka Medical center

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

nadav belfair

Role: CONTACT

Phone: 086403347

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

sor478308ctil

Identifier Type: -

Identifier Source: org_study_id